BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18536689)

  • 21. Molecular markers of breast axillary lymph node metastasis.
    Cavalli LR
    Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
    Delloye-Bourgeois C; Brambilla E; Coissieux MM; Guenebeaud C; Pedeux R; Firlej V; Cabon F; Brambilla C; Mehlen P; Bernet A
    J Natl Cancer Inst; 2009 Feb; 101(4):237-47. PubMed ID: 19211441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
    Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Road map to metastasis.
    Van't Veer LJ; Weigelt B
    Nat Med; 2003 Aug; 9(8):999-1000. PubMed ID: 12894162
    [No Abstract]   [Full Text] [Related]  

  • 25. Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.
    Yin Y; Chen X; Shu Y
    Biomed Pharmacother; 2009 Jul; 63(6):421-8. PubMed ID: 19564093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lineage infidelity and expression of melanocytic markers in human breast cancer.
    Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U
    Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New advances in breast cancer metastasis.
    Russo J; Han HJ; Kohwi Y; Kohwi-Shigematsu T
    Womens Health (Lond); 2008 Nov; 4(6):547-9. PubMed ID: 19072455
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemokine decoy receptor d6 plays a negative role in human breast cancer.
    Wu FY; Ou ZL; Feng LY; Luo JM; Wang LP; Shen ZZ; Shao ZM
    Mol Cancer Res; 2008 Aug; 6(8):1276-88. PubMed ID: 18708360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma.
    Wang XC; Wu YP; Ye B; Lin DC; Feng YB; Zhang ZQ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
    Mol Cancer Res; 2009 Jan; 7(1):12-22. PubMed ID: 19147533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for genes associated with ovarian cancer prognosis.
    Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H
    Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MAG-2 promotes invasion, mobility and adherence capability of lung cancer cells by MMP-2, CD44 and intracellular calcium in vitro.
    Zhang J; Liu G; Meng Y; Lin H; Lu Y
    Oncol Rep; 2009 Mar; 21(3):697-706. PubMed ID: 19212629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected preferential brain metastases with a human breast tumor cell line MDA-MB-231 in BALB/c nude mice.
    El-Mabhouh AA; Nation PN; Kaddoura A; Mercer JR
    Vet Pathol; 2008 Nov; 45(6):941-4. PubMed ID: 18984801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer metastasis: when, where, how?
    Eccles SA; Paon L
    Lancet; 2005 Mar 19-25; 365(9464):1006-7. PubMed ID: 15781080
    [No Abstract]   [Full Text] [Related]  

  • 37. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
    Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S
    Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
    Iorio MV; Casalini P; Tagliabue E; Ménard S; Croce CM
    Eur J Cancer; 2008 Dec; 44(18):2753-9. PubMed ID: 19022662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential.
    Tome Y; Tsuchiya H; Hayashi K; Yamauchi K; Sugimoto N; Kanaya F; Tomita K; Hoffman RM
    J Cell Biochem; 2009 Oct; 108(2):362-7. PubMed ID: 19623575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a metastasizing human breast cancer cell line in nude mice.
    Otake Y
    Fukushima J Med Sci; 1980 Jun; 27(1-2):53-62. PubMed ID: 7333570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.